Dermatology Research and Practice

Dermatology Research and Practice / 2016 / Article

Research Article | Open Access

Volume 2016 |Article ID 3284937 |

Swastika Suvirya, Alpna Thakur, S. S. Pandey, S. K. Tripathi, Durgesh Kumar Dwivedi, "Altered Levels of Serum Zinc and Cadmium in Patients with Chronic Vesiculobullous Hand and Feet Dermatitis", Dermatology Research and Practice, vol. 2016, Article ID 3284937, 5 pages, 2016.

Altered Levels of Serum Zinc and Cadmium in Patients with Chronic Vesiculobullous Hand and Feet Dermatitis

Academic Editor: Markus Stucker
Received26 Nov 2015
Accepted13 Mar 2016
Published06 Apr 2016


Micronutrients serve many important functions in our body and altered levels of heavy and trace metals are associated with cutaneous and systemic disorders. Vesicular palmoplantar eczema is an entity whose etiopathogenesis is a mystery. In this prospective case-noncase study blood levels of Zinc and Cadmium in 37 patients of chronic vesiculobullous hand dermatitis were estimated and compared with 40 noncases with similar age and gender distributions. Low serum Zinc levels were found in patients as compared to noncases. The mean difference of serum Zinc between the case and noncase groups was 27.26; the mean value of serum Zinc between the two groups was statistically significant (). However, elevated Cadmium levels were detected in only 5 patients and in none of the noncases. The mean concentration of serum Cadmium was μg/dL, with a range of 1.90–2.80 μg/dL for the five cases in whom Cadmium was detected. Various toxic and trace metals can interact by influencing each other’s absorption, retention, distribution, and bioavailability in the body. The clinical significance of this finding lies in the possible beneficial role of Zinc supplementation in the therapy of chronic vesiculobullous hand dermatitis.

1. Introduction

Vesicular palmoplantar eczema is characterised clinically by small to large blisters in the hands and feet and histologically by spongiosis. Its etiopathogenesis remains obscure. It is divided into 4 categories: pompholyx, chronic vesiculobullous hand dermatitis, hyperkeratotic hand dermatitis, and id reactions [1]. However, in many dermatology textbooks, this classification is not followed and vesicular eczema of hands and feet, dyshidrotic eczema, and pompholyx are synonymous and used interchangeably [2].

Chronic vesiculobullous hand dermatitis is difficult to manage because of its relapsing course. Contact allergy, ingestion of metals, atopy, psychological stress, and hot weather are all postulated to play a role in its pathogenesis. The clinical presentation includes small 1 to 2 mm vesicles filled with clear fluid localizing to the lateral aspects of the fingers, palms, and soles. With time, the clinical appearance may evolve and subsequently appear more fissured and hyperkeratotic [1].

Zinc is involved in numerous aspects of cellular metabolism. It is required for the catalytic activity of more than 200 enzymes and it plays a role in immune function, wound healing, protein synthesis, DNA synthesis, and cell division. Zinc has antioxidant properties, which may protect against accelerated aging and helps speed up the healing process after an injury [3].

Low levels of Zinc have been found in hair and erythrocytes of patients of atopic dermatitis (AD). Zinc supplementation has led to improvement in scores assessing severity in AD [4]. Cadmium is a toxic heavy metal found in low concentrations in blood or is generally undetectable [5]. Elevated levels are found in smokers and persons residing in industrial areas [6]. Altered Zinc/Cadmium ratios have been found in industrial workers and also in certain disorders like prostate cancer [7], decreased renal function [8], hypertension, and coronary artery disease as various toxic and trace metals can interact by influencing each other’s absorption, retention, distribution, and bioavailability in the body. Toxicity of Cadmium has been found to be dependent on disturbance in Zinc metabolism, earning the name of “antimetabolite” of Zinc [7]. Thus, there is a need to estimate the levels of serum Zinc and Cadmium in patients with chronic vesiculobullous hand dermatitis.

2. Methods

The study was a prospective case-noncase study carried out in the dermatology outpatient department for one-year period. The protocol was approved by the institutional ethics committee. The study population included 37 cases with chronic vesiculobullous hand dermatitis and 40 age and sex similar noncases. Inclusion criteria were duration of vesicular eczema for more than 6 weeks, bilateral lesions on palms, and/or soles (Figures 1, 2, and 3). Patients suffering from generalized diseases, having lesions on other parts of body, and cases of allergic contact dermatitis were excluded from the study. Skin scraping for fungus and patch testing with Indian Standard Patch Test Battery approved by the Contact and Occupational Dermatosis Forum of India (CODFI) were done to rule out other types of hand eczema, like contact dermatitis and id reactions. Forty noncases with similar age and gender distribution were taken who were suffering from benign dermatological disorders like acne (), melasma (), pityriasis versicolor (), tuberculoid Hansen’s disease (), and borderline tuberculoid Hansen’s disease (). The noncases taken in the study did not have any generalized diseases and hand and foot eczema on examination nor had any history of eczema.

About 5 mL of blood was collected in ethylenediaminetetraacetate vial and stored in the refrigerator immediately at 4°C and later transported to the laboratory in Department of Forensic Medicine. The concentration of Zinc and Cadmium was estimated by Atomic Absorption Flame Spectrophotometer (Model number SL-194; ELICO), which is a double beam spectrophotometer. Data was entered into a MS EXCEL database and analyzed using SPSS version 10.00 for Windows. Data were described using appropriate summary measures. The statistical tests used in the study were unpaired -test and chi-square test. A value <0.05 was considered significant.

3. Results

Table 1 shows history of signs, symptoms, and clinical profile of cases. The comparison of epidemiological profile of cases and noncases is shown in Table 2. Table 3 shows comparison of serum level of Zinc and Cadmium between cases and noncases. Figure 4 shows ratio of serum Zinc and Cadmium in cases where both metals were detected.

VariablesNumber of cases%

Duration of itching
<3 months2567.6
4 to <6 months513.5
>6 months513.5
No itching25.4
Intensity of itching
Diurnal variation in itching
More in daytime1437.8
More in night38.1
No diurnal variation1848.6
Duration of skin lesions
<3 months2773
4–6 months513.5
>6 months513.5
Past history of recurrent disease
Previous treatment taken
No treatment38.1
Personal history of atopy
Family history of atopy
Site of lesions
Palmar areas of hand2978.4
Sides of finger37100
Dorsum of hand1951.4
Dorsum of foot38.1
Only on hands3081.1
Both hands and feet718.9
Pattern of lesions

VariablesCases ()Noncases () value

Marital status
Diet type

Chi-square test used.
value < 0.05 is significant.


Mean difference27.26
95% CI of differences21.86–32.661.84–2.79

Independent -test used.
value < 0.05 is significant.

Zinc was detected in sera of all the cases and noncases. The range of serum Zinc in cases was 17.20–57.90 μg/dL and in noncases was 42.00–102.20 μg/dL. The mean of serum Zinc in 37 cases was μg/dL, whereas, for the 40 in noncase group, the mean of serum Zinc was μg/dL. The mean difference of serum Zinc between the case and noncase groups was 27.26. This difference was found to be statistically significant (). The 95% confidence interval of the difference between serum concentrations was 21.86 to 32.66.

There was no statistically significant difference in concentration of serum Zinc with regard to the place of residence (urban versus rural; -test, all ), dietary habits (vegetarian versus nonvegetarian; -test, all ), age groups (-test, all ), or gender (, ). This is similar to the observation by Hashim et al. that concentration of serum Zinc does not vary with age or gender [9].

Cadmium in blood could be detected in only 5 cases, with the mean concentration being μg/dL and in the range 1.90–2.80 μg/dL. Cadmium was below detectable levels (BDL) in rest of 32 cases and in all the 40 noncases. The BDL for Cadmium was 0.009 ppm for the instrument.

4. Discussion

A number of etiologic factors have been associated with vesicular palmoplantar eczema, including atopy, contact allergy, psychological stress, and hot weather. Crosti and Lodi found that patients with pompholyx had no sweat gland dysfunction or dyshidrosis as was previously thought, although hyperhidrosis could be an exacerbating factor [10]. In another study by Lodi et al. of 104 patients, they found that hyperhidrosis was the exacerbating factor in 37% patients [11]. In our study, only 1 out of 37 (2.7%) cases had palmoplantar hyperhidrosis as the exacerbating factor.

In a study by Lodi et al. of 104 patients of pompholyx, personal or family history of atopy was found in 50% of the patients versus 11.5% of noncases [11]. Others have found no association between atopy and pompholyx [1214]. In our study, 3 patients (8.1%) had history of similar complaints in first-degree relative, while 34 (91.8%) had no such history. Genetic predisposition to vesicular palmoplantar eczema has been noted [15].

Clinical presentation of chronic vesiculobullous hand dermatitis includes small 1-2 mm vesicles filled with clear fluid, most commonly seen on the lateral aspect of fingers, palms, and soles. Similarly, lesions of pompholyx develop symmetrically on the palms and/or soles in a typical case. In 80% of patients of pompholyx only the hands are involved while in 10% of the patients hands and feet both are involved. Rubbing and inappropriate treatment may produce secondary eczematous changes. With time, the lesions become fissured and hyperkeratotic. Secondary infection with pustule formation is not uncommon in patients of pompholyx [1, 2].

The essentiality of Zinc for humans was recognized in 1961 [16]. Zinc deficiency is common in many developing nations. Diets based on cereals and legumes and poor in animal products make it difficult to meet the Zinc requirements because their high phytate content reduces the bioavailability of Zinc [17]. Zinc has been found to be low in children with atopic dermatitis [4]. Epidermal Zinc concentration was found to be low in patients with dermatitis herpetiformis, acne, psoriasis, and Darier’s disease [18]. Measurement of plasma Zinc in psoriasis has resulted in conflicting data with both reduced and normal levels being reported [19]. Serum Zinc levels were found to be significantly low in patients of psoriasis, acne vulgaris, and leprosy [20].

The range of serum Zinc in our study cases was 17.20–57.90 μg/dL and in noncase group, it was 42.00–102.20 μg/dL. With the normal serum and plasma concentration of Zinc ranging between 70 and 100 μg/dL [9], cases in our study were clearly Zinc deficient.

Studies on mice fed on a Zinc deficient diet have shown that Zinc deficiency leads to development of more severe skin lesions as compared to controls, with higher transepidermal water loss in deficient mice. Levels of IgE, interferon γ (INFγ), and interleukin-13 (IL-13) were also raised in Zinc deficient mice [21]. In humans, Zinc deficiency has been reported to cause an imbalance between Th1 and Th2 cells: the Th1 function is decreased, while Th2 function is not affected, with increase in the production of IFNγ, IL-2, and tumour necrosis factor α (TNFα) [22]. Studies done with cell culture models show decrease in NF-κB activation with subsequent decrease in inflammatory cytokine production (like TNFα, IL-1β, and IL-8). Thus, Zinc deficiency leads to increased Th2 cytokines and reduced anti-inflammatory effects, leading to possible eczema-like skin lesions [23]. This could also be a possible reason for chronic vesiculobullous hand dermatitis in our Zinc deficient cases.

Cadmium is a toxic heavy metal normally not detectable in blood, with normal levels <0.5 μg/100 mL [5]. High concentrations are however found in smokers and persons exposed to industrial fumes [6]. Since it was detected in only 5 patients in our study, its role in pathogenesis seemed doubtful and was not analyzed further.

Till date, there is no study indicating that Zinc could play a role in the pathogenesis of patients with vesicular hand dermatitis. In the present study, serum Zinc was found to be significantly low and below the normal range in patients of vesicular palmoplantar eczema. Also we could not estimate the elements a second time when lesions had subsided. Exact role of Zinc in the pathogenesis of chronic vesiculobullous hand dermatitis needs to be studied further.

5. Conclusion

The present study points towards a possible, hitherto unknown, association of Zinc deficiency in patients of chronic recurrent vesicular hand dermatitis. The clinical significance of this finding lies in the possible beneficial role of Zinc supplementation in the therapy of palmoplantar vesicular eczema.

To confirm our findings regarding levels of Zinc and vesicular palmoplantar eczema, a large scale prospective study with a long follow-up and further analysis is needed. A detailed estimation of these metals at various stages of the disease is needed. This will help in providing proper insight into their role in the pathogenesis of vesicular palmoplantar eczema. Further, clinical therapeutic trials would also be needed to substantiate a role for Zinc supplementation in these patients.

Competing Interests

The authors declare no conflict of interests.


  1. D. N. Doshi, C. E. Cheng, and A. B. Kimball, “Vesicular palmoplantar eczema,” in Fitzpatrick's Dermatology in General Medicine, L. A. Goldsmith, S. I. Katz, B. A. Gilchrest, A. S. Paller, D. J. Leffell, and K. Wolff, Eds., pp. 187–197, McGraw Hill Medical, New Delhi, India, 8th edition, 2012. View at: Google Scholar
  2. J. B. Jones, “Eczema, lichenification, prurigo & erythroderma,” in Rook's Textbook of Dermatology, T. Burns, S. Breathnach, N. Cox, and C. Griffiths, Eds., pp. 23.1–23.51, Wiley-Blackwell, Singapore, 8th edition, 2010. View at: Google Scholar
  3. J. Osredkar and N. Sustar, “Copper and zinc, biological role and significance of copper/zinc imbalance,” Journal of Clinical Toxicology, vol. 3, article 001, 2011. View at: Publisher Site | Google Scholar
  4. J. E. Kim, S. R. Yoo, M. G. Jeong, J. Y. Ko, and Y. S. Ro, “Hair zinc levels and the efficacy of oral zinc supplementation in children with atopic dermatitis,” Acta Dermato-Venereologica, vol. 94, no. 5, pp. 558–562, 2014. View at: Publisher Site | Google Scholar
  5. V. Foà and L. Alessio, “Biological monitoring,” in Encyclopedia of Occupational Health and Safety, J. M. Steelman, Ed., chapter 27, International Labour Office, Geneva, Switzerland, 1998. View at: Google Scholar
  6. A. Pizent, J. Jurasović, and S. Telišman, “Serum calcium, zinc, and copper in relation to biomarkers of lead and cadmium in men,” Journal of Trace Elements in Medicine and Biology, vol. 17, no. 3, pp. 199–205, 2003. View at: Publisher Site | Google Scholar
  7. J. I. Anetor, F. Ajose, G. O. Anetor, A. A. Iyanda, O. O. Babalola, and F. A. Adeniyi, “High cadmium / zinc ratio in cigarette smokers: potential implications as a biomarker of risk of prostate cancer,” Nigerian Journal of Physiological Sciences, vol. 23, no. 1-2, pp. 41–49, 2008. View at: Google Scholar
  8. Y.-S. Lin, W.-C. Ho, J. L. Caffrey, and B. Sonawane, “Low serum zinc is associated with elevated risk of cadmium nephrotoxicity,” Environmental Research, vol. 134, pp. 33–38, 2014. View at: Publisher Site | Google Scholar
  9. Z. Hashim, L. Woodhouse, and J. C. King, “Interindividual variation in circulating zinc concentrations among healthy adult men and women,” International Journal of Food Sciences and Nutrition, vol. 47, no. 5, pp. 383–390, 1996. View at: Publisher Site | Google Scholar
  10. C. Crosti and A. Lodi, “Pompholyx: a still unresolved kind of eczema,” Dermatology, vol. 186, no. 4, pp. 241–242, 1993. View at: Publisher Site | Google Scholar
  11. A. Lodi, R. Betti, G. Chiarelli, C. E. Urbani, and C. Crosti, “Epidemiological, clinal and allergological observations on pompholyx,” Contact Dermatitis, vol. 26, no. 1, pp. 17–21, 1992. View at: Publisher Site | Google Scholar
  12. E. M. De Boer, D. P. Bruynzeel, and W. G. Van Ketel, “Dyshidrotic eczema as an occupational dermatitis in metal workers,” Contact Dermatitis, vol. 19, no. 3, pp. 184–188, 1988. View at: Publisher Site | Google Scholar
  13. B. Edman, “Palmar eczema: a pathogenetic role for acetylsalicylic acid, contraceptives and smoking?” Acta Dermato-Venereologica, vol. 68, no. 5, pp. 402–407, 1988. View at: Google Scholar
  14. M. P. Lehucher-Michel, M. C. Koeppel, A. Lanteaume, and J. Sayag, “Dyshidrotic eczema and occupation: a descriptive study,” Contact Dermatitis, vol. 43, no. 4, pp. 200–205, 2000. View at: Publisher Site | Google Scholar
  15. J.-J. Chen, Y.-H. Liang, F.-S. Zhou et al., “The gene for a rare autosomal dominant form of pompholyx maps to chromosome 18q22.1-18q22.3,” Journal of Investigative Dermatology, vol. 126, no. 2, pp. 300–304, 2006. View at: Publisher Site | Google Scholar
  16. J. C. King and R. J. Cousins, “Zinc,” in Modern Nutrition in Health and Disease, M. E. Shils, M. Shike, A. C. Ross, B. Caballero, and R. J. Cousins, Eds., pp. 271–285, Lippincott Williams & Wilkins, Baltimore, Md, USA, 10th edition, 2006. View at: Google Scholar
  17. N. Roohani, R. Hurrell, R. Kelishadi, and R. Schulin, “Zinc and its importance for human health: an integrative review,” Journal of Research in Medical Sciences, vol. 18, no. 2, pp. 144–157, 2013. View at: Google Scholar
  18. G. Michaelsson and K. Ljunghall, “Patients with dermatitis herpetiformis, acne, psoriasis and Darier's disease have low epidermal zinc concentrations,” Acta Dermato-Venereologica, vol. 70, no. 4, pp. 304–308, 1990. View at: Google Scholar
  19. L. J. Hinks, S. Young, and B. Clayton, “Trace element status in eczema and psoriasis,” Clinical and Experimental Dermatology, vol. 12, no. 2, pp. 93–97, 1987. View at: Publisher Site | Google Scholar
  20. B. P. N. Arora, M. K. S. Dhillon, S. R. Rajan, C. S. K. Sayal, and C. A. L. Das, “Serum zinc levels in cutaneous disorders,” Medical Journal Armed Forces India, vol. 58, no. 4, pp. 304–306, 2002. View at: Publisher Site | Google Scholar
  21. F. W. J. Beck, A. S. Prasad, J. Kaplan, J. T. Fitzgerald, and G. J. Brewer, “Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans,” American Journal of Physiology-Endocrinology and Metabolism, vol. 272, no. 6, pp. E1002–E1007, 1997. View at: Google Scholar
  22. A. S. Prasad, “Effects of zinc deficiency on Th1 and Th2 cytokine shifts,” Journal of Infectious Diseases, vol. 182, supplement 1, pp. S62–S68, 2000. View at: Publisher Site | Google Scholar
  23. A. S. Prasad, “Zinc in human health: effect of zinc on immune cells,” Molecular Medicine, vol. 14, no. 5-6, pp. 353–357, 2008. View at: Publisher Site | Google Scholar

Copyright © 2016 Swastika Suvirya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.